How the U.K. healthcare sector is leveraging its strengths to beat COVID-19

Crisis is the mother of invention and COVID-19 is no exception. But amid all the gloom are signs of a nascent revolution in how we create and develop new drugs, vaccines and diagnostics. The U.K. life sciences industry is rising to the challenge with a mix of collaboration, speed, creativity and resource commitment, to capitalize on the science and technology it has invested in over the last few years.

This unprecedented rapid ramping-up of R&D will help the U.K. to not only find the solutions to this pandemic, but also help us to prepare for the next one and lay the foundations for a new life science industrial strategy...